Profile | GDS4284 / 1559436_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 4242.84 | 92 |
GSM687648 | Patient 402 control | 5135.67 | 93 |
GSM687653 | Patient 403 control | 4236.78 | 92 |
GSM687658 | Patient 404 control | 7981.44 | 96 |
GSM687663 | Patient 411 control | 9149.57 | 97 |
GSM687668 | Patient 422 control | 5930.83 | 94 |
GSM687673 | Patient 424 control | 7641.95 | 96 |
GSM687678 | Patient 425 control | 5589.24 | 94 |
GSM687683 | Patient 427 control | 8033.81 | 96 |
GSM687688 | Patient 428 control | 5524.25 | 94 |
GSM687695 | Patient 441 control | 7858.01 | 96 |
GSM687699 | Patient 443 control | 6124.63 | 95 |
GSM687704 | Patient 444 control | 9121.17 | 97 |
GSM687707 | Patient 448 control | 10000.2 | 97 |
GSM687712 | Patient 449 control | 4939.78 | 93 |
GSM687719 | Patient 450 control | 7219.72 | 96 |
GSM687724 | Patient 451 control | 11383.5 | 97 |
GSM687728 | Patient 452 control | 7892.88 | 96 |
GSM687646 | Patient 401 treated 24h | 5601.97 | 94 |
GSM687649 | Patient 402 treated 24h | 4744.7 | 93 |
GSM687665 | Patient 411 treated 24h | 5778.35 | 94 |
GSM687651 | Patient 402 treated 4 weeks | 6038.22 | 95 |
GSM687667 | Patient 411 treated 4 weeks | 4705.91 | 93 |
GSM687670 | Patient 422 treated 24h | 6389.44 | 95 |
GSM687671 | Patient 422 treated 4 weeks | 7091.13 | 96 |
GSM687654 | Patient 403 treated 24h | 4476.74 | 92 |
GSM687675 | Patient 424 treated 24h | 6211.51 | 95 |
GSM687685 | Patient 427 treated 24h | 6604.86 | 95 |
GSM687656 | Patient 403 treated 4 weeks | 4186.56 | 92 |
GSM687677 | Patient 424 treated 4 weeks | 9601.2 | 97 |
GSM687687 | Patient 427 treated 4 weeks | 5852.59 | 94 |
GSM687692 | Patient 428 treated 4h | 7884.45 | 96 |
GSM687716 | Patient 449 treated 4h | 6833.1 | 95 |
GSM687722 | Patient 450 treated 4h | 6845.63 | 95 |
GSM687680 | Patient 425 treated 24h | 4578.2 | 93 |
GSM687690 | Patient 428 treated 24h | 5542.14 | 94 |
GSM687700 | Patient 443 treated 24h | 8700.52 | 97 |
GSM687705 | Patient 444 treated 24h | 9881.47 | 97 |
GSM687714 | Patient 449 treated 24h | 5069.19 | 93 |
GSM687721 | Patient 450 treated 24h | 5855.19 | 95 |
GSM687682 | Patient 425 treated 4 weeks | 6745.42 | 95 |
GSM687694 | Patient 428 treated 4 weeks | 7816.59 | 96 |
GSM687702 | Patient 443 treated 4 weeks | 6798.71 | 95 |
GSM687718 | Patient 449 treated 4 weeks | 11596.9 | 97 |
GSM687723 | Patient 450 treated 4 weeks | 5235.65 | 94 |
GSM687661 | Patient 404 treated 4h | 6337.77 | 95 |
GSM687710 | Patient 448 treated 4h | 7229.55 | 95 |
GSM687726 | Patient 451 treated 4h | 10860.2 | 97 |
GSM687730 | Patient 452 treated 4h | 33215.4 | 99 |
GSM687660 | Patient 404 treated 24h | 7222.15 | 95 |
GSM687697 | Patient 441 treated 24h | 10811.9 | 97 |
GSM687709 | Patient 448 treated 24h | 9288.84 | 97 |
GSM687725 | Patient 451 treated 24h | 8991.5 | 97 |
GSM687729 | Patient 452 treated 24h | 9089.79 | 96 |
GSM687727 | Patient 451 treated 4 weeks | 15384.9 | 98 |
GSM687731 | Patient 452 treated 4 weeks | 5971.02 | 95 |